| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |